A COVID-19 Survey among People Who Use Drugs in Norway.  Welle-Strand GK, Gjersing L, Olsen IK, Clausen T.  Int J Environ Res Public Health. 2022 Jun 8;19(12):7002. doi: 10.3390/ijerph19127002. PMID: 35742252; PMCID: PMC9222643. https:/…

Impact of COVID-19 among people who use drugs: A qualitative study with harm reduction workers and people who use drugs.  Conway FN, Samora J, Brinkley K, Jeong H, Clinton N, Claborn KR.  Harm Reduct J. 2022 Jul 2;19(1):72. doi: 10.1186/…

Mixed methods prospective findings of the initial effects of the U.S. COVID-19 pandemic on individuals in recovery from substance use disorder.  Shircliff K, Liu M, Prestigiacomo C, Fry M, Ladd K, Gilbert MK, Rattermann MJ, Cyders MA.  P…

Racial/Ethnic disparities in drug use during the COVID 19 pandemic: Moderating effects of non-profit substance use disorder service expenditures.  Ji H, Shin SH, Rogers A, Neese J, Lee HY.  PLoS One. 2022 Jun 30;17(6):e0270238. doi: 10.1…

WHO sieht starken Anstieg bei psychischen Krankheiten durch Corona Genf – Die Coronapandemie hat zu einem deutlichen Anstieg einiger psychischer Krankheiten geführt. Die Fälle von Depressionen und Angststörungen seien weltweit allein im ersten Pand…

The Cathinone Hydra: Increased Cathinone and caffeine adulteration in the English MDMA market after Brexit and COVID-19 lockdowns.  Pascoe MJ, Radley S, Simmons HTD, Measham F Drug Science, Policy and Law. January 2022. doi:10…